Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

HIV Infection

Free Subscription Articles published in J Virol Retrieve available abstracts of 164 articles: HTML format

Single Articles

November 2023
1. MIN AK, Javidfar B, Missall R, Doanman D, et al
   HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model.
   J Virol. 2023 Nov 30:e0159523. doi: 10.1128/jvi.01595.
   PubMed     Abstract available
   
   
   
2. LEE S-C, Naik NG, Tombacz D, Gulyas G, et al
   Hypoxia and HIF-1alpha promote lytic de novo KSHV infection.
   J Virol. 2023;97:e0097223.
   PubMed     Abstract available
   
   
   
3. CHANG J, Parent LJ
   HIV-1 Gag co-localizes with euchromatin histone marks at the nuclear periphery.
   J Virol. 2023 Nov 22:e0117923. doi: 10.1128/jvi.01179.
   PubMed     Abstract available
   
   
   
4. YAPO V, Majumder K, Tedbury PR, Wen X, et al
   HIV-2 inhibits HIV-1 gene expression via two independent mechanisms during cellular co-infection.
   J Virol. 2023 Nov 22:e0187022. doi: 10.1128/jvi.01870.
   PubMed     Abstract available
   
   
   
5. LIU Y, Binda CS, Berkhout B, Das AT, et al
   CRISPR-Cas attack of HIV-1 proviral DNA can cause unintended deletion of surrounding cellular DNA.
   J Virol. 2023 Nov 20:e0133423. doi: 10.1128/jvi.01334.
   PubMed     Abstract available
   
   
   October 2023
6. YANDRAPALLY S, Sarkar S, Banerjee S
   HIV-1 Tat commandeers nuclear export of Rev-viral RNA complex by controlling hnRNPA2-mediated splicing.
   J Virol. 2023 Oct 31:e0104423. doi: 10.1128/jvi.01044.
   PubMed     Abstract available
   
   
   
7. ANANG S, Zhang S, Fritschi C, Chiu T-J, et al
   V3 tip determinants of susceptibility to inhibition by CD4-mimetic compounds in natural clade A human immunodeficiency virus (HIV-1) envelope glycoproteins.
   J Virol. 2023 Oct 27:e0117123. doi: 10.1128/jvi.01171.
   PubMed     Abstract available
   
   
   
8. WANG L, Howell MEA, Hensley CR, Ning K, et al
   The master antioxidant defense is activated during EBV latent infection.
   J Virol. 2023 Oct 25:e0095323. doi: 10.1128/jvi.00953.
   PubMed     Abstract available
   
   
   
9. KUSE N, Gatanaga H, Zhang Y, Chikata T, et al
   Epitope-dependent effect of long-term cART on maintenance and recovery of HIV-1-specific CD8(+) T cells.
   J Virol. 2023 Oct 25:e0102423. doi: 10.1128/jvi.01024.
   PubMed     Abstract available
   
   
   
10. EVANGELOUS TD, Berry M, Venkatayogi S, LeMaster C, et al
    Host immunity associated with spontaneous suppression of viremia in therapy-naive young rhesus macaques following neonatal SHIV infection.
    J Virol. 2023 Oct 24:e0109423. doi: 10.1128/jvi.01094.
    PubMed     Abstract available
    
    
    
11. PADRON A, Prakash P, Pandhare J, Luban J, et al
    Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus.
    J Virol. 2023 Oct 16:e0073223. doi: 10.1128/jvi.00732.
    PubMed     Abstract available
    
    
    
12. BARTON K, Ferguson JM, Deveson IW, Falcinelli SD, et al
    HIVepsilon-seq-scalable characterization of intact persistent proviral HIV reservoirs in women.
    J Virol. 2023 Oct 16:e0070523. doi: 10.1128/jvi.00705.
    PubMed     Abstract available
    
    
    
13. SONG E, Lee SK, Dykxhoorn DM, Novina C, et al
    Correction for Song et al., "Sustained Small Interfering RNA-Mediated Human Immunodeficiency Virus Type 1 Inhibition in Primary Macrophages".
    J Virol. 2023 Oct 13:e0093623. doi: 10.1128/jvi.00936.
    PubMed    
    
    
    
14. VAN DUIJN J, Stieh D, Fernandez N, King D, et al
    Mosaic HIV-1 vaccination induces anti-viral CD8(+) T cell functionality in the phase 1/2a clinical trial APPROACH.
    J Virol. 2023 Oct 9:e0112623. doi: 10.1128/jvi.01126.
    PubMed     Abstract available
    
    
    
15. LERNER G, Ding L, Spearman P
    Tryptophan-based motifs in the LLP3 region of the HIV-1 envelope glycoprotein cytoplasmic tail direct trafficking to the endosomal recycling compartment and mediate particle incorporation.
    J Virol. 2023 Oct 5:e0063123. doi: 10.1128/jvi.00631.
    PubMed     Abstract available
    
    
    September 2023
16. PINCUS SH, Stackhouse M, Watt C, Ober K, et al
    Soluble CD4 and low molecular weight CD4-mimetic compounds sensitize cells to be killed by anti-HIV cytotoxic immunoconjugates.
    J Virol. 2023 Sep 29:e0115423. doi: 10.1128/jvi.01154.
    PubMed     Abstract available
    
    
    
17. NKUWI E, Judicate GP, Tan TS, Barabona G, et al
    Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity.
    J Virol. 2023 Sep 28:e0082323. doi: 10.1128/jvi.00823.
    PubMed     Abstract available
    
    
    
18. SCHULZ VE, Tuff JF, Tough RH, Lewis L, et al
    Host genetic variation at a locus near CHD1L impacts HIV sequence diversity in a South African population.
    J Virol. 2023 Sep 25:e0095423. doi: 10.1128/jvi.00954.
    PubMed     Abstract available
    
    
    
19. KRCHLIKOVA V, Lotke R, Haussmann I, Reinisova M, et al
    Independent loss events of a functional tetherin gene in galliform birds.
    J Virol. 2023 Sep 15:e0080323. doi: 10.1128/jvi.00803.
    PubMed     Abstract available
    
    
    
20. OGUNDIRAN AI, Chang TL, Ivanov A, Kumari N, et al
    Shear-reversible clusters of HIV-1 in solution: stabilized by antibodies, dispersed by mucin.
    J Virol. 2023 Sep 15:e0075223. doi: 10.1128/jvi.00752.
    PubMed     Abstract available
    
    
    
21. DAHAL S, Clayton K, Cabral T, Cheng R, et al
    On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine.
    J Virol. 2023 Sep 14:e0039623. doi: 10.1128/jvi.00396.
    PubMed     Abstract available
    
    
    
22. ZHANG Z, Wang Q, Nguyen HT, Chen HC, et al
    Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.
    J Virol. 2023 Sep 11:e0059223. doi: 10.1128/jvi.00592.
    PubMed     Abstract available
    
    
    
23. ZGHEIB S, Taha N, Zeiger M, Glushonkov O, et al
    The human cellular protein NoL12 is a specific partner of the HIV-1 nucleocapsid protein NCp7.
    J Virol. 2023 Sep 11:e0004023. doi: 10.1128/jvi.00040.
    PubMed     Abstract available
    
    
    
24. RAO PG, Lambert GS, Upadhyay C
    Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.
    J Virol. 2023 Sep 8:e0071023. doi: 10.1128/jvi.00710.
    PubMed     Abstract available
    
    
    
25. KHARYTONCHYK S, Burnett C, Gc K, Telesnitsky A, et al
    Transcription start site heterogeneity and its role in RNA fate determination distinguish HIV-1 from other retroviruses and are mediated by core promoter elements.
    J Virol. 2023 Sep 8:e0081823. doi: 10.1128/jvi.00818.
    PubMed     Abstract available
    
    
    
26. HSIEH SH, Yu FH, Huang KJ, Wang CT, et al
    HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
    J Virol. 2023 Sep 6:e0094823. doi: 10.1128/jvi.00948.
    PubMed     Abstract available
    
    
    
27. HORVATH RM, Brumme ZL, Sadowski I
    CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells.
    J Virol. 2023 Sep 6:e0092323. doi: 10.1128/jvi.00923.
    PubMed     Abstract available
    
    
    August 2023
28. YI Y, Zankharia U, Cassel JA, Lu F, et al
    A high-throughput screening assay for silencing established HIV-1 macrophage infection identifies nucleoside analogs that perturb H3K9me3 on proviral genomes.
    J Virol. 2023 Aug 14:e0065323. doi: 10.1128/jvi.00653.
    PubMed     Abstract available
    
    
    
29. LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
    Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
    J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
    PubMed     Abstract available
    
    
    July 2023
30. JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
    Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
    PubMed     Abstract available
    
    
    June 2023
31. WEAVER N, Hammonds J, Ding L, Lerner G, et al
    KIF16B Mediates Anterograde Transport and Modulates Lysosomal Degradation of the HIV-1 Envelope Glycoprotein.
    J Virol. 2023 Jun 26:e0025523. doi: 10.1128/jvi.00255.
    PubMed     Abstract available
    
    
    
32. ORTIZ AM, Castello Casta F, Rahmberg A, Markowitz TE, et al
    2-Hydroxypropyl-beta-Cyclodextrin Treatment Induces Modest Immune Activation in Healthy Rhesus Macaques.
    J Virol. 2023 Jun 20:e0060023. doi: 10.1128/jvi.00600.
    PubMed     Abstract available
    
    
    
33. VAIDYANATHAN A, Taylor HE, Hope TJ, D'Aquila RT, et al
    Analysis of the Contribution of 6-mer Seed Toxicity to HIV-1-Induced Cytopathicity.
    J Virol. 2023 Jun 13:e0065223. doi: 10.1128/jvi.00652.
    PubMed     Abstract available
    
    
    
34. PETERSEN M, Lotke R, Hopfensperger K, Victoria S, et al
    Inhibition of Infectious HIV-1 Production by Rerouting the Cellular Furin Inhibitor Serpin B8.
    J Virol. 2023 Jun 5:e0029423. doi: 10.1128/jvi.00294.
    PubMed     Abstract available
    
    
    May 2023
35. YUAN Z, Huang Y, Sadikot RT
    Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes HIV-1 Replication through Modulating microRNAs in Macrophages.
    J Virol. 2023 May 31:e0005323. doi: 10.1128/jvi.00053.
    PubMed     Abstract available
    
    
    
36. ZHOU R, Zhang S, Nguyen HT, Ding H, et al
    Conformations of Human Immunodeficiency Virus Envelope Glycoproteins in Detergents and Styrene-Maleic Acid Lipid Particles.
    J Virol. 2023 May 31:e0032723. doi: 10.1128/jvi.00327.
    PubMed     Abstract available
    
    
    
37. ZHANG RZ, Mele V, Robben L, Kane M, et al
    Genetic Differences between 129S Substrains Affect Antiretroviral Immune Responses.
    J Virol. 2023;97:e0193022.
    PubMed     Abstract available
    
    
    
38. SAMER S, Chowdhury A, Wiche Salinas TR, Estrada PMDR, et al
    Lymph-Node-Based CD3(+) CD20(+) Cells Emerge from Membrane Exchange between T Follicular Helper Cells and B Cells and Increase Their Frequency following Simian Immunodeficiency Virus Infection.
    J Virol. 2023 May 23:e0176022. doi: 10.1128/jvi.01760.
    PubMed     Abstract available
    
    
    
39. MALIKOV V, Naghavi MH
    FEZ1 Plays Dual Roles in Early HIV-1 Infection by Independently Regulating Capsid Transport and Host Interferon-Stimulated Gene Expression.
    J Virol. 2023 May 23:e0049923. doi: 10.1128/jvi.00499.
    PubMed     Abstract available
    
    
    
40. OLIVEIRA MF, Pankow A, Vollbrecht T, Kumar NM, et al
    Evaluation of Archival HIV DNA in Brain and Lymphoid Tissues.
    J Virol. 2023 May 15:e0054323. doi: 10.1128/jvi.00543.
    PubMed     Abstract available
    
    
    
41. DEKKER JG, Klaver B, Berkhout B, Das AT, et al
    HIV-1 3'-Polypurine Tract Mutations Confer Dolutegravir Resistance by Switching to an Integration-Independent Replication Mechanism via 1-LTR Circles.
    J Virol. 2023 May 1:e0036123. doi: 10.1128/jvi.00361.
    PubMed     Abstract available
    
    
    April 2023
42. SCHATZ M, Marty L, Ounadjela C, Tong PBV, et al
    A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity.
    J Virol. 2023;97:e0027823.
    PubMed     Abstract available
    
    
    
43. SASTRY M, Changela A, Gorman J, Xu K, et al
    Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.
    J Virol. 2023 Apr 26:e0160422. doi: 10.1128/jvi.01604.
    PubMed     Abstract available
    
    
    
44. YIM LY, Lam KS, Luk TY, Mo Y, et al
    Transforming Growth Factor beta Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4(+) T Cells.
    J Virol. 2023 Apr 12:e0027023. doi: 10.1128/jvi.00270.
    PubMed     Abstract available
    
    
    March 2023
45. CHAPPELL DL, Sandhu PK, Wong JP, Bhatt AP, et al
    KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle.
    J Virol. 2023;97:e0176322.
    PubMed     Abstract available
    
    
    
46. STAMOS JD, Rahman MA, Gorini G, Silva de Castro I, et al
    Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or beta-Sheet Conformations on Time of SIV(mac251) Acquisition.
    J Virol. 2023 Mar 28:e0186422. doi: 10.1128/jvi.01864.
    PubMed     Abstract available
    
    
    
47. MALLARINO-HAEGER C, Pino M, Viox EG, Pagliuzza A, et al
    HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy.
    J Virol. 2023 Mar 27:e0167022. doi: 10.1128/jvi.01670.
    PubMed     Abstract available
    
    
    
48. LU Y, Pang W, Zhang MD, Song JH, et al
    A Novel Vpu Adaptive Mutation of HIV-1 Degrades Tetherin in Northern Pig-Tailed Macaques (Macaca leonina) Mainly via the Ubiquitin-Proteasome Pathway and Increases Viral Release.
    J Virol. 2023 Mar 27:e0020023. doi: 10.1128/jvi.00200.
    PubMed     Abstract available
    
    
    
49. DESROSIERS RC
    The Failure of AIDS Vaccine Efficacy Trials: Where to Go from Here.
    J Virol. 2023 Mar 14:e0021123. doi: 10.1128/jvi.00211.
    PubMed     Abstract available
    
    
    February 2023
50. NGUYEN HT, Wang Q, Anang S, Sodroski JG, et al
    Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.
    J Virol. 2023 Feb 23:e0185722. doi: 10.1128/jvi.01857.
    PubMed     Abstract available
    
    
    
51. OHKURA S, Horie M, Shimizu M, Nakagawa S, et al
    Characterization of Megabat-Favored, CA-Dependent Susceptibility to Retrovirus Infection.
    J Virol. 2023 Feb 13:e0180322. doi: 10.1128/jvi.01803.
    PubMed     Abstract available
    
    
    
52. KURIAKOSE GIFT S, Wieczorek L, Sanders-Buell E, Zemil M, et al
    Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.
    J Virol. 2023 Feb 7:e0163522. doi: 10.1128/jvi.01635.
    PubMed     Abstract available
    
    
    
53. WAGNER V, Sabachvili M, Bendl E, Fuchs J, et al
    The Antiviral Activity of Equine Mx1 against Thogoto Virus Is Determined by the Molecular Structure of Its Viral Specificity Region.
    J Virol. 2023 Feb 7:e0193822. doi: 10.1128/jvi.01938.
    PubMed     Abstract available
    
    
    January 2023
54. DURAN-CASTELLS C, Llano A, Kawana-Tachikawa A, Prats A, et al
    Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
    J Virol. 2023 Jan 31:e0165522. doi: 10.1128/jvi.01655.
    PubMed     Abstract available
    
    
    
55. MUKIM A, Smith DM, Deshmukh S, Qazi AA, et al
    A Camptothetin Analog, Topotecan, Promotes HIV Latency via Interference with HIV Transcription and RNA Splicing.
    J Virol. 2023 Jan 31:e0163022. doi: 10.1128/jvi.01630.
    PubMed     Abstract available
    
    
    
56. WRAPP D, Mu Z, Thakur B, Janowska K, et al
    Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and Yield.
    J Virol. 2023 Jan 12:e0167322. doi: 10.1128/jvi.01673.
    PubMed     Abstract available
    
    
    
57. LISTA MJ, Ficarelli M, Wilson H, Kmiec D, et al
    A Nuclear Export Signal in KHNYN Required for Its Antiviral Activity Evolved as ZAP Emerged in Tetrapods.
    J Virol. 2023 Jan 12:e0087222. doi: 10.1128/jvi.00872.
    PubMed     Abstract available
    
    
    
58. TEMEROZO JR, Ferreira PLC, Linhares-Lacerda L, Vieira RC, et al
    Interleukin-27 Promotes Divergent Effects on HIV-1 Infection in Peripheral Blood Mononuclear Cells through BST-2/Tetherin.
    J Virol. 2023 Jan 5:e0175222. doi: 10.1128/jvi.01752.
    PubMed     Abstract available
    
    
    December 2022
59. KIM S, Filsinger Interrante MV, Kim PS
    Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
    J Virol. 2022 Dec 21:e0164722. doi: 10.1128/jvi.01647.
    PubMed     Abstract available
    
    
    
60. WEDRYCHOWSKI A, Martin HA, Li Y, Telwatte S, et al
    Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control.
    J Virol. 2022 Dec 21:e0125422. doi: 10.1128/jvi.01254.
    PubMed     Abstract available
    
    
    
61. PAL S, Jaiswal V, Nala N, Ranga U, et al
    Enhanced Transcriptional Strength of HIV-1 Subtype C Minimizes Gene Expression Noise and Confers Stability to the Viral Latent State.
    J Virol. 2022 Dec 19:e0137622. doi: 10.1128/jvi.01376.
    PubMed     Abstract available
    
    
    
62. NAZLI A, Chow R, Zahoor MA, Workenhe ST, et al
    LAMP3/CD63 Expression in Early and Late Endosomes in Human Vaginal Epithelial Cells Is Associated with Enhancement of HSV-2 Infection.
    J Virol. 2022;96:e0155322.
    PubMed     Abstract available
    
    
    
63. WOOLLEY G, Mosher M, Kroll K, Jones R, et al
    Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events.
    J Virol. 2022 Dec 13:e0151922. doi: 10.1128/jvi.01519.
    PubMed     Abstract available
    
    
    
64. MATSUMOTO K, Kuwata T, Tolbert WD, Richard J, et al
    Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates.
    J Virol. 2022 Dec 13:e0163822. doi: 10.1128/jvi.01638.
    PubMed     Abstract available
    
    
    
65. CHEN Y, Wu Y, Chen S, Zhan Q, et al
    Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
    J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
    PubMed     Abstract available
    
    
    
66. MANDIZVO T, Gumede N, Ndlovu B, Ndlovu S, et al
    Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C Infection.
    J Virol. 2022 Dec 1:e0127022. doi: 10.1128/jvi.01270.
    PubMed     Abstract available
    
    
    November 2022
67. MARTIN HA, Kadiyala GN, Telwatte S, Wedrychowski A, et al
    New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals.
    J Virol. 2022 Nov 30:e0160522. doi: 10.1128/jvi.01605.
    PubMed     Abstract available
    
    
    
68. YANG Z, Dam KA, Gershoni JM, Zolla-Pazner S, et al
    Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
    J Virol. 2022 Nov 30:e0108222. doi: 10.1128/jvi.01082.
    PubMed     Abstract available
    
    
    
69. CHANDRASEKAR AP, Cummins NW, Natesampillai S, Misra A, et al
    The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model.
    J Virol. 2022 Nov 30:e0173022. doi: 10.1128/jvi.01730.
    PubMed     Abstract available
    
    
    
70. DUNHAM D, Viswanathan P, Gill J, Manzano M, et al
    Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
    J Virol. 2022 Nov 23:e0136022. doi: 10.1128/jvi.01360.
    PubMed     Abstract available
    
    
    
71. HARWOOD OE, Balgeman AJ, Weaver AJ, Ellis-Connell AL, et al
    Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803.
    J Virol. 2022 Nov 15:e0142422. doi: 10.1128/jvi.01424.
    PubMed     Abstract available
    
    
    
72. SHARIFI HJ, Paine DN, Fazzari VA, Tipple AF, et al
    Sulforaphane Reduces SAMHD1 Phosphorylation To Protect Macrophages from HIV-1 Infection.
    J Virol. 2022 Nov 15:e0118722. doi: 10.1128/jvi.01187.
    PubMed     Abstract available
    
    
    
73. FERNANDEZ-DE CESPEDES MV, Hoffman HK, Carter H, Simons LM, et al
    Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4(+) T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines.
    J Virol. 2022 Nov 10:e0087622. doi: 10.1128/jvi.00876.
    PubMed     Abstract available
    
    
    
74. RODRIGUEZ W, Mehrmann T, Hatfield D, Muller M, et al
    Shiftless Restricts Viral Gene Expression and Influences RNA Granule Formation during Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    J Virol. 2022 Nov 3:e0146922. doi: 10.1128/jvi.01469.
    PubMed     Abstract available
    
    
    
75. ZHANG Y, Chikata T, Kuse N, Murakoshi H, et al
    Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
    J Virol. 2022 Nov 3:e0124822. doi: 10.1128/jvi.01248.
    PubMed     Abstract available
    
    
    October 2022
76. GRUENBACH M, Muller CKS, Schlaepfer E, Baroncini L, et al
    cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice.
    J Virol. 2022 Oct 17:e0082722. doi: 10.1128/jvi.00827.
    PubMed     Abstract available
    
    
    
77. WANG Y, Zhao K, Zhao Y, Zhao Z, et al
    Nef Suppresses LINE-1 Retrotransposition through Two Distinct Mechanisms.
    J Virol. 2022 Oct 5:e0114822. doi: 10.1128/jvi.01148.
    PubMed     Abstract available
    
    
    
78. DUAN Y, Wang X, Sun K, Lin Y, et al
    SYNJ2BP Improves the Production of Lentiviral Envelope Protein by Facilitating the Formation of Mitochondrion-Associated Endoplasmic Reticulum Membrane.
    J Virol. 2022 Oct 5:e0054922. doi: 10.1128/jvi.00549.
    PubMed     Abstract available
    
    
    
79. ELLIS-CONNELL AL, Balgeman AJ, Harwood OE, Moriarty RV, et al
    Control of Simian Immunodeficiency Virus Infection in Prophylactically Vaccinated, Antiretroviral Treatment-Naive Macaques Is Required for the Most Efficacious CD8 T Cell Response during Treatment with the Interleukin-15 Superagonist N-803.
    J Virol. 2022 Oct 3:e0118522. doi: 10.1128/jvi.01185.
    PubMed     Abstract available
    
    
    September 2022
80. NGUYEN HT, Kuse N, Zhang Y, Murakoshi H, et al
    Control of HIV-1 Replication by CD8(+) T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection.
    J Virol. 2022 Sep 26:e0081122. doi: 10.1128/jvi.00811.
    PubMed     Abstract available
    
    
    
81. SAPP N, Burge N, Cox K, Prakash P, et al
    HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA.
    J Virol. 2022 Sep 12:e0101122. doi: 10.1128/jvi.01011.
    PubMed     Abstract available
    
    
    
82. ZHANG X, Li J, Zhang M, Bai B, et al
    A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
    J Virol. 2022 Sep 7:e0098622. doi: 10.1128/jvi.00986.
    PubMed     Abstract available
    
    
    August 2022
83. FILES JK, Sterrett S, Henostroza S, Fucile C, et al
    HLA-II-Associated HIV-1 Adaptation Decreases CD4(+) T-Cell Responses in HIV-1 Vaccine Recipients.
    J Virol. 2022 Aug 24:e0119122. doi: 10.1128/jvi.01191.
    PubMed     Abstract available
    
    
    
84. HE X, Aid M, Ventura JD, Borducchi E, et al
    Rapid Loss of CD4 T Cells by Pyroptosis during Acute SIV Infection in Rhesus Macaques.
    J Virol. 2022 Aug 24:e0080822. doi: 10.1128/jvi.00808.
    PubMed     Abstract available
    
    
    
85. ANANG S, Richard J, Bourassa C, Goyette G, et al
    Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
    J Virol. 2022 Aug 18:e0063622. doi: 10.1128/jvi.00636.
    PubMed     Abstract available
    
    
    
86. WOODBURN BM, Kanchi K, Zhou S, Colaianni N, et al
    Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation.
    J Virol. 2022 Aug 17:e0095722. doi: 10.1128/jvi.00957.
    PubMed     Abstract available
    
    
    
87. DUAN S, Yu X, Wang C, Meng L, et al
    Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
    J Virol. 2022 Aug 11:e0055522. doi: 10.1128/jvi.00555.
    PubMed     Abstract available
    
    
    
88. JONES ST, Guo K, Cooper EH, Dillon SM, et al
    Altered Immunoglobulin Repertoire and Decreased IgA Somatic Hypermutation in the Gut during Chronic HIV-1 Infection.
    J Virol. 2022 Aug 8:e0097622. doi: 10.1128/jvi.00976.
    PubMed     Abstract available
    
    
    
89. WANG XQ, Zerbato JM, Avihingsanon A, Fisher K, et al
    Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
    J Virol. 2022 Aug 2:e0058822. doi: 10.1128/jvi.00588.
    PubMed     Abstract available
    
    
    
90. BUCKMASTER MV, Goff SP
    Riplet Binds the Zinc Finger Antiviral Protein (ZAP) and Augments ZAP-Mediated Restriction of HIV-1.
    J Virol. 2022 Aug 1:e0052622. doi: 10.1128/jvi.00526.
    PubMed     Abstract available
    
    
    July 2022
91. RUDICELL RS, Piel AK, Stewart F, Moore DL, et al
    Correction for Rudicell et al., "High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees".
    J Virol. 2022 Jul 26:e0045122. doi: 10.1128/jvi.00451.
    PubMed    
    
    
    
92. WIETGREFE SW, Duan L, Anderson J, Marques G, et al
    Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.
    J Virol. 2022 Jul 20:e0088522. doi: 10.1128/jvi.00885.
    PubMed     Abstract available
    
    
    
93. ALBALAWI YA, Narasipura SD, Olivares LJ, Al-Harthi L, et al
    CD4(dim) CD8(bright) T Cells Home to the Brain and Mediate HIV Neuroinvasion.
    J Virol. 2022 Jul 19:e0080422. doi: 10.1128/jvi.00804.
    PubMed     Abstract available
    
    
    
94. MACEDO AB, Levinger C, Nguyen BN, Richard J, et al
    The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
    J Virol. 2022 Jul 14:e0037222. doi: 10.1128/jvi.00372.
    PubMed     Abstract available
    
    
    
95. BAKER EJ, Hughes K, Travieso T, Klotman ME, et al
    Establishment, Persistence, and Reactivation of Latent HIV-1 Infection in Renal Epithelial Cells.
    J Virol. 2022 Jul 5:e0062422. doi: 10.1128/jvi.00624.
    PubMed     Abstract available
    
    
    
96. RATCLIFF AN, Venner CM, Olabode AS, Knapp J, et al
    Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.
    J Virol. 2022 Jul 5:e0185121. doi: 10.1128/jvi.01851.
    PubMed     Abstract available
    
    
    June 2022
97. HOFFMAN HK, Aguilar RS, Clark AR, Groves NS, et al
    Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14(+) Late Endosomes and Lysosomes to Regulate Surface Levels in T-Cell Lines.
    J Virol. 2022 Jun 30:e0076722. doi: 10.1128/jvi.00767.
    PubMed     Abstract available
    
    
    
98. KAO S, Miyagi E, Mallorson R, Saito H, et al
    The Myeloid-Specific Transcription Factor PU.1 Upregulates Mannose Receptor Expression but Represses Basal Activity of the HIV-LTR Promoter.
    J Virol. 2022 Jun 29:e0065222. doi: 10.1128/jvi.00652.
    PubMed     Abstract available
    
    
    
99. AVILA-RIOS S, Garcia-Morales C, Reyes-Teran G, Gonzalez-Rodriguez A, et al
    Phylodynamics of HIV in the Mexico City Metropolitan Region.
    J Virol. 2022 Jun 28:e0070822. doi: 10.1128/jvi.00708.
    PubMed     Abstract available
    
    
    
100. RICHETTA C, Subra F, Malet I, Leh H, et al
     Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
     J Virol. 2022 Jun 27:e0067622. doi: 10.1128/jvi.00676.
     PubMed     Abstract available
     
     
     
101. SHEWARD DJ, Hermanus T, Murrell B, Garrett N, et al
     HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies.
     J Virol. 2022 Jun 27:e0032422. doi: 10.1128/jvi.00324.
     PubMed     Abstract available
     
     
     
102. PEDERSEN SF, Collora JA, Kim RN, Yang K, et al
     Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition Screen.
     J Virol. 2022 Jun 22:e0057722. doi: 10.1128/jvi.00577.
     PubMed     Abstract available
     
     
     
103. LIN J, Law R, Korosec CS, Zhou C, et al
     Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
     J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
     PubMed     Abstract available
     
     
     
104. JOSEPH KW, Halvas EK, Brandt LD, Patro SC, et al
     Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal Repeats.
     J Virol. 2022 Jun 8:e0012222. doi: 10.1128/jvi.00122.
     PubMed     Abstract available
     
     
     
105. ROJAS CHAVEZ RA, Boyt D, Schwery N, Han C, et al
     Commonly Elicited Antibodies against the Base of the HIV-1 Env Trimer Guide the Population-Level Evolution of a Structure-Regulating Region in gp41.
     J Virol. 2022 Jun 6:e0040622. doi: 10.1128/jvi.00406.
     PubMed     Abstract available
     
     
     May 2022
106. KLEINMAN AJ, Sivanandham S, Sette P, Sivanandham R, et al
     Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations.
     J Virol. 2022 May 31:e0044522. doi: 10.1128/jvi.00445.
     PubMed     Abstract available
     
     
     
107. PETERS RJ, Stevenson M
     Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-kappaB Activity.
     J Virol. 2022 May 23:e0048422. doi: 10.1128/jvi.00484.
     PubMed     Abstract available
     
     
     
108. PEI Z, Wang H, Zhao Z, Chen X, et al
     Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage.
     J Virol. 2022 May 17:e0043522. doi: 10.1128/jvi.00435.
     PubMed     Abstract available
     
     
     
109. TU JJ, Kumar A, Giorgi EE, Eudailey J, et al
     Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
     J Virol. 2022 May 10:e0023122. doi: 10.1128/jvi.00231.
     PubMed     Abstract available
     
     
     
110. SACKS D, Wiehe K, Morris L, Moore PL, et al
     Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.
     J Virol. 2022 May 5:e0027022. doi: 10.1128/jvi.00270.
     PubMed     Abstract available
     
     
     
111. BUTTA GM, Bozzi G, Gallo G, Copaloni G, et al
     Heterogeneity of Latency Establishment in the Different Human CD4(+) T Cell Subsets Stimulated with IL-15.
     J Virol. 2022 May 2:e0037922. doi: 10.1128/jvi.00379.
     PubMed     Abstract available
     
     
     April 2022
112. CIENIEWICZ B, Kirillov V, Daher I, Li X, et al
     IKKalpha-Mediated Noncanonical NF-kappaB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.
     J Virol. 2022 Apr 28:e0002722. doi: 10.1128/jvi.00027.
     PubMed     Abstract available
     
     
     
113. CHIKATA T, Paes W, Kuse N, Partridge T, et al
     Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
     J Virol. 2022 Apr 27:e0043222. doi: 10.1128/jvi.00432.
     PubMed     Abstract available
     
     
     
114. TABLER CO, Wegman SJ, Chen J, Shroff H, et al
     The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release.
     J Virol. 2022 Apr 19:e0219821. doi: 10.1128/jvi.02198.
     PubMed     Abstract available
     
     
     
115. RESOP RS, Bosque A
     Pharmacological Targeting of Sphingosine Kinases Impedes HIV-1 Infection of CD4 T Cells through SAMHD1 Modulation.
     J Virol. 2022 Apr 12:e0009622. doi: 10.1128/jvi.00096.
     PubMed     Abstract available
     
     
     
116. KLASSE PJ, Moore JP
     Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
     J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
     PubMed     Abstract available
     
     
     March 2022
117. NGUYEN HT, Qualizza A, Anang S, Zhao M, et al
     Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.
     J Virol. 2022 Mar 28:e0166821. doi: 10.1128/jvi.01668.
     PubMed     Abstract available
     
     
     
118. LU F, Zankharia U, Vladimirova O, Yi Y, et al
     Epigenetic Landscape of HIV-1 Infection in Primary Human Macrophage.
     J Virol. 2022 Mar 23:e0016222. doi: 10.1128/jvi.00162.
     PubMed     Abstract available
     
     
     
119. HOTZEL I
     Deep-Time Structural Evolution of Retroviral and Filoviral Surface Envelope Proteins.
     J Virol. 2022 Mar 23:e0006322. doi: 10.1128/jvi.00063.
     PubMed     Abstract available
     
     
     
120. XIANG J, Lu M, Shi M, Cheng X, et al
     Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
     J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
     PubMed     Abstract available
     
     
     
121. YERO A, Farnos O, Clain J, Zghidi-Abouzid O, et al
     Impact of Early ARV Initiation on Relative Proportions of Effector and Regulatory CD8 T Cell in Mesenteric Lymph Nodes and Peripheral Blood During Acute SIV Infection of Rhesus Macaques.
     J Virol. 2022 Mar 21:e0025522. doi: 10.1128/jvi.00255.
     PubMed     Abstract available
     
     
     
122. COGSWELL A, Jo S, Ferguson N, Gupta K, et al
     Presence of Natural Killer B Cells in Simian Immunodeficiency Virus-Infected Colon That Have Properties and Functions Similar to Those of Natural Killer Cells and B Cells but Are a Distinct Cell Population.
     J Virol. 2022 Mar 21:e0023522. doi: 10.1128/jvi.00235.
     PubMed     Abstract available
     
     
     
123. ANWAR A, Helou M, Hervol J, Levine AD, et al
     Impact of Caveolin-Mediated Endocytosis on the Trafficking of HIV within the Colonic Barrier.
     J Virol. 2022 Mar 17:e0020222. doi: 10.1128/jvi.00202.
     PubMed     Abstract available
     
     
     
124. CHEN SMY, Wong YC, Yim LY, Zhang H, et al
     Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
     J Virol. 2022 Mar 17:e0216121. doi: 10.1128/jvi.02161.
     PubMed     Abstract available
     
     
     
125. BRICKER KM, Obregon-Perko V, Williams B, Oliver D, et al
     Altered Response Pattern following AZD5582 Treatment of SIV-Infected, ART-Suppressed Rhesus Macaque Infants.
     J Virol. 2022 Mar 16:e0169921. doi: 10.1128/jvi.01699.
     PubMed     Abstract available
     
     
     
126. WANG Q, Esnault F, Zhao M, Chiu TJ, et al
     Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.
     J Virol. 2022 Mar 15:e0187821. doi: 10.1128/jvi.01878.
     PubMed     Abstract available
     
     
     
127. CARLIN E, Greer B, Lowman K, Dalecki AG, et al
     Lentiviral Nef Proteins Differentially Govern the Establishment of Viral Latency.
     J Virol. 2022 Mar 10:e0220621. doi: 10.1128/jvi.02206.
     PubMed     Abstract available
     
     
     February 2022
128. FISHER K, Wang XQ, Lee A, Morcilla V, et al
     Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes.
     J Virol. 2022 Feb 24:jvi0201121. doi: 10.1128/jvi.02011.
     PubMed     Abstract available
     
     
     
129. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
     Correction for Elsayed et al., "Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines".
     J Virol. 2022;96:e0195421.
     PubMed    
     
     
     
130. MIKI S, Kawai Y, Nakayama-Hosoya K, Iwabuchi R, et al
     Sustainable antiviral efficacy of rejuvenated HIV-specific cytotoxic T lymphocytes generated from induced pluripotent stem cells.
     J Virol. 2022 Feb 2:jvi0221721. doi: 10.1128/jvi.02217.
     PubMed     Abstract available
     
     
     January 2022
131. PREVOST J, Richard J, Gasser R, Medjahed H, et al
     Detection of the HIV-1 accessory proteins Nef and Vpu by flow cytometry represents a new tool to study their functional interplay within a single infected CD4+ T cell.
     J Virol. 2022 Jan 26:jvi0192921. doi: 10.1128/jvi.01929.
     PubMed     Abstract available
     
     
     
132. OHATA Y, Tomonaga M, Watanabe Y, Tomura K, et al
     Antiviral Activity and Resistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor, JTP-0157602.
     J Virol. 2022 Jan 19:JVI0184321. doi: 10.1128/JVI.01843.
     PubMed     Abstract available
     
     
     
133. RICHTER E, Bornemann L, Korencak M, Alter G, et al
     Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors.
     J Virol. 2022 Jan 12:JVI0173021. doi: 10.1128/JVI.01730.
     PubMed     Abstract available
     
     
     
134. DALECKI AG, Greer BD, Duverger A, Strange EL, et al
     Host T cell dedifferentiation effects drive HIV-1 latency stability.
     J Virol. 2022 Jan 12:jvi0197421. doi: 10.1128/jvi.01974.
     PubMed     Abstract available
     
     
     December 2021
135. VAN DORSTEN RT, Reh L, Trkola A, Morris L, et al
     Single-chain variable fragments of broadly neutralizing antibodies prevent HIV cell-cell transmission.
     J Virol. 2021 Dec 22:jvi0193421. doi: 10.1128/jvi.01934.
     PubMed     Abstract available
     
     
     
136. ETTICH J, Werner J, Weitz HT, Mueller E, et al
     A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
     J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
     PubMed     Abstract available
     
     
     
137. CHESARINO NM, Emerman M
     HIV-1 Vif gained breadth in APOBEC3G specificity after cross-species transmission of its precursors.
     J Virol. 2021 Dec 15:JVI0207121. doi: 10.1128/JVI.02071.
     PubMed     Abstract available
     
     
     
138. HANY L, Turmel MO, Barat C, Ouellet M, et al
     Bryostatin-1 decreases HIV-1 infection and viral production in human primary macrophages.
     J Virol. 2021 Dec 8:JVI0195321. doi: 10.1128/JVI.01953.
     PubMed     Abstract available
     
     
     
139. YAO W, Strebel K, Yamaoka S, Yoshida T, et al
     SIVgsn-99CM71 Vpu employs different amino acids to antagonize human and greater spot-nosed monkey BST-2.
     J Virol. 2021 Dec 8:JVI0152721. doi: 10.1128/JVI.01527.
     PubMed     Abstract available
     
     
     November 2021
140. HOLGUIN L, Echavarria L, Burnetta JC
     Novel humanized-PBMC mouse model with delayed onset of GVHD for preclinical HIV research.
     J Virol. 2021 Nov 24:JVI0139421. doi: 10.1128/JVI.01394.
     PubMed     Abstract available
     
     
     
141. WU C, He Y, Zhao J, Luo K, et al
     Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption.
     J Virol. 2021 Nov 24:JVI0178521. doi: 10.1128/JVI.01785.
     PubMed     Abstract available
     
     
     
142. BELLON M, Nicot C
     Feedback Loop Regulation Between Pim Kinases and Tax Keeps HTLV-I Viral Replication in Check.
     J Virol. 2021 Nov 24:JVI0196021. doi: 10.1128/JVI.01960.
     PubMed     Abstract available
     
     
     
143. ALVARADO-HERNANDEZ B, Ma Y, Sharma NR, Majerciak V, et al
     Protein-RNA interactome analysis reveals wide association of KSHV ORF57 with host non-coding RNAs and polysomes.
     J Virol. 2021 Nov 17:JVI0178221. doi: 10.1128/JVI.01782.
     PubMed     Abstract available
     
     
     
144. HEMSATH JR, Liaci AM, Rubin JD, Parrett BJ, et al
     Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).
     J Virol. 2021 Nov 17:JVI0082621. doi: 10.1128/JVI.00826.
     PubMed     Abstract available
     
     
     
145. VIEIRA VA, Adland E, Grayson NE, Csala A, et al
     Two distinct mechanisms leading to loss of virological control in the rare group of antiretroviral therapy-naive, transiently aviraemic children living with HIV.
     J Virol. 2021 Nov 10:JVI0153521. doi: 10.1128/JVI.01535.
     PubMed     Abstract available
     
     
     
146. CHEN J, Zhao S, Cui Z, Li W, et al
     MicroRNA-376b-3p Promotes Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Restriction Factor TRIM22.
     J Virol. 2021 Nov 10:JVI0159721. doi: 10.1128/JVI.01597.
     PubMed     Abstract available
     
     
     
147. WANG XF, Wang YH, Bai B, Zhang M, et al
     Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.
     J Virol. 2021;95:e0108721.
     PubMed     Abstract available
     
     
     
148. DUGGAN NN, Weisgrau KL, Magnani DM, Rakasz EG, et al
     SOSIP trimer-specific antibodies isolated from a SHIV-infected monkey with versus without a pre-blocking step with gp41.
     J Virol. 2021 Nov 3:JVI0158221. doi: 10.1128/JVI.01582.
     PubMed     Abstract available
     
     
     
149. MIELKE D, Stanfield-Oakley S, Borate B, Fisher LH, et al
     Selection of HIV Envelope strains for standardized assessments of vaccine-elicited antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies.
     J Virol. 2021 Nov 3:JVI0164321. doi: 10.1128/JVI.01643.
     PubMed     Abstract available
     
     
     
150. GACH JS, Matsuno SY, Mercado M, Hangartner L, et al
     Internalization of HIV-1 by phagocytes is increased when virions are opsonized with multimeric antibody in the presence of complement.
     J Virol. 2021 Nov 3:JVI0168921. doi: 10.1128/JVI.01689.
     PubMed     Abstract available
     
     
     
151. ZHAO Y, Du J, Wang Y, Wang Q, et al
     BST2 suppresses LINE-1 retrotransposition by reducing the promoter activity of LINE-1 5'-UTR.
     J Virol. 2021 Nov 3:JVI0161021. doi: 10.1128/JVI.01610.
     PubMed     Abstract available
     
     
     October 2021
152. YU J, Collins ND, Mercado NB, McMahan K, et al
     Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
     J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
     PubMed     Abstract available
     
     
     
153. HOTZEL I
     Domain Organization of Lentiviral and Betaretroviral Surface Envelope Glycoproteins Modeled with AlphaFold.
     J Virol. 2021 Oct 27:JVI0134821. doi: 10.1128/JVI.01348.
     PubMed     Abstract available
     
     
     
154. SCHORCHT A, Cottrell CA, Pugach P, Ringe RP, et al
     The glycan hole area of HIV-1 envelope trimers contributes prominently to the induction of autologous neutralization.
     J Virol. 2021 Oct 20:JVI0155221. doi: 10.1128/JVI.01552.
     PubMed     Abstract available
     
     
     
155. COLOMER-LLUCH M, Kilpelainen A, Pernas M, Pena R, et al
     Viral and Cellular factors leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.
     J Virol. 2021 Oct 20:JVI0149921. doi: 10.1128/JVI.01499.
     PubMed     Abstract available
     
     
     
156. BELTRAN-PAVEZ C, Bontjer I, Gonzalez N, Pernas M, et al
     Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle (VLP) Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
     J Virol. 2021 Oct 20:JVI0134321. doi: 10.1128/JVI.01343.
     PubMed     Abstract available
     
     
     
157. CACCURI F, Neves V, Gano L, Correia JDG, et al
     The HIV-1 matrix protein p17 does cross the Blood-Brain Barrier.
     J Virol. 2021 Oct 20:JVI0120021. doi: 10.1128/JVI.01200.
     PubMed     Abstract available
     
     
     
158. BENNER BE, Bruce JW, Kentala JR, Murray M, et al
     Perturbing HIV-1 ribosomal frameshifting frequency reveals a cis preference for Gag-Pol incorporation into assembling virions.
     J Virol. 2021 Oct 13:JVI0134921. doi: 10.1128/JVI.01349.
     PubMed     Abstract available
     
     
     
159. BALAMURUGAN A, Ng HL, Yang OO
     Correction for Balamurugan et al., "Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones".
     J Virol. 2021;95:e0139721.
     PubMed    
     
     
     
160. SOWD GA, Shi J, Aiken C
     HIV-1 CA inhibitors are antagonized by inositol phosphate stabilization of the viral capsid in cells.
     J Virol. 2021 Oct 6:JVI0144521. doi: 10.1128/JVI.01445.
     PubMed     Abstract available
     
     
     
161. KURNAEVA MA, Zalevsky AO, Arifulin EA, Lisitsyna OM, et al
     Molecular coevolution of nuclear and nucleolar localization signals inside basic domain of HIV-1 Tat.
     J Virol. 2021 Oct 6:JVI0150521. doi: 10.1128/JVI.01505.
     PubMed     Abstract available
     
     
     September 2021
162. NAGEL L, Kant S, Leeks C, Routy JP, et al
     Evolution of antibodies to native trimeric envelope and their Fc dependent functions in untreated and treated primary HIV infection.
     J Virol. 2021 Sep 29:JVI0162521. doi: 10.1128/JVI.01625.
     PubMed     Abstract available
     
     
     
163. TORRENTS DE LA PENA A, Del Moral Sanchez I, Burger JA, Bontjer I, et al
     Targeted destabilization of the HIV-1 gp120-gp41 interface leads to convergent evolution with mutations in the V1V2, HR1 and HR2 domains.
     J Virol. 2021 Sep 29:JVI0053221. doi: 10.1128/JVI.00532.
     PubMed     Abstract available
     
     
     August 2021
164. NCHIOUA R, Kmiec D, Gaba A, Sturzel CM, et al
     APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans.
     J Virol. 2021;95:e0080821.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.